Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Vir Biotechnology Inc

(NASDAQ: VIR)
Add to Portfolio
-0.58 (-4.26%)
as of Dec 5, 2019

Profile
Ticker Symbol VIR
Exchange NASDAQ
Contact Information
499 ILLINOIS STREET SUITE 500
SAN FRANCISCO, CA USA
P: 415-906-4324
CEO/President
Earnings at a Glance
Price Earnings Ratio N/A
EPS Growth N/A
Most Recent Earnings ($) -4.60
Annual EPS ($) N/A
Business Summary
Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus influenza A human immunodeficiency virus and tuberculosis. Vir Biotechnology Inc. is based in San Francisco United States.
Industry/Sector Information not available.